Back to search results

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Gastrointestinal Stromal Tumor (GIST)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • HonorHealth, Scottsdate, Arizona, United States

    Contact: Study coordinator (Program Management) · hriprograms@honorhealth.com

  • UC San Diego Moores Cancer Center, La Jolla, California, United States

  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

    Contact: Study coordinator (Steven Sares) · steven.sares@cuanschutz.edu · 303-724-9889

  • Mayo Clinic Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Caroline Teeter) · teeter.caroline@mayo.edu · 904-953-5141

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Leah Anton, ARNP) · lxa712@med.miami.edu · 305-243-2529

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Study coordinator · 617-632-5204

  • START Midwest, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Hope Team) · hopeteam@startresearch.com

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Jordan Meyers) · Meyers.jordan@mayo.edu · 507-284-2030

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Ping Chi, MD) · chip@mskcc.org · 646-888-4166

  • Vanderbilt University-Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Vanderbilt-Ingram Cancer Center Clinical Trials Office (CTO) · CTIP@VUMC.ORG · 800-811-8480
Study leads

  • Clinical Team

    Study Director

    Deciphera Pharmaceuticals, LLC

View source on ClinicalTrials.gov(opens in a new tab)